Scage Future (SCAG) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 30, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Nov 12, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SCAG SEC filings page.
Scage Future (SCAG) reported $11.1M in revenue for fiscal year 2025, up 82.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).
Sales expanded rapidly, but costs and overhead expanded faster, leaving a cash-consuming business increasingly dependent on financing.
Revenue grew82.0% while cost of revenue grew112.3% ; the business added volume without preserving unit economics. Operating cash flow of-$5.89M was less negative than the net loss of$12.9M , indicating non-cash charges and working-capital movements softened the cash effect of reported losses.
The balance sheet became more constrained: liabilities reached
FY2025 free cash flow was negative despite capital expenditures of only
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Scage Future's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Scage Future held $20.4M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $5.9M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Scage Future scores 68/100 among other emerging companies.
Scage Future had 72M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Scage Future scores 21/100 among other emerging companies.
Scage Future spent $1.5M on research and development in fiscal year 2025, which was 6.3% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Scage Future scores 28/100 among other emerging companies.
Scage Future reported revenue of $11.1M in fiscal year 2025, against $6.1M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Scage Future scores 96/100 among other emerging companies.
Scage Future's operations used $5.9M of cash in fiscal year 2025, against $6.2M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Scage Future scores 39/100 among other emerging companies.
Scage Future's cash, cash equivalents and investments came to $20.4M at the end of fiscal year 2025, against $27.4M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Scage Future scores 54/100 among other emerging companies.
Scage Future scores -4.08, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $40.2M against total assets of $26.5M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Scage Future passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
Scage Future reported a net loss of $12.9M while operations used $5.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Scage Future reported an operating loss of $13.4M against $338K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Scage Future generated $11.1M in revenue in fiscal year 2025. This represents an increase of 82.0% from the prior year.
Scage Future's EBITDA was -$13.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. The change from the prior year is not meaningful, because that figure was zero or negative.
Scage Future reported a net loss of $12.9M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
Cash & Balance Sheet
Scage Future recorded an outflow of $5.9M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.
Scage Future held $91K in cash as of fiscal year 2025; no long-term debt figure is on record for that period.
Not reported for fiscal year 2025.
Margins & Returns
Scage Future's gross margin was -6.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 15.2 percentage points from the prior year.
Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for fiscal year 2025.
Capital Allocation
Scage Future invested $1.5M in research and development in fiscal year 2025. This represents a decrease of 9.0% from the prior year.
Scage Future invested $13K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 73.7% from the prior year.
Not reported for fiscal year 2025.
SCAG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F |
|---|---|---|---|
| Revenue | $11.1M+82.0% | $6.1M+1295.3% | $438K |
| Cost of Revenue | $11.8M+112.3% | $5.6M+601.0% | $795K |
| Gross Profit | -$713K-232.9% | $536Kn/m | -$357K |
| R&D Expenses | $1.5M-9.0% | $1.7M-26.1% | $2.3M |
| SG&A Expenses | $11.1M+146.2% | $4.5M+11.0% | $4.1M |
| Operating Income | -$13.4Mn/m | -$5.9Mn/m | -$6.7M |
| EBITDA | -$13.1Mn/m | -$5.3Mn/m | -$6.3M |
| Interest Expense | $338K-8.5% | $370K+144.1% | $151K |
| Net Income | -$12.9Mn/m | -$5.8Mn/m | -$6.4M |
| EPS (Basic) | -$0.18 | -$0.15n/m | -$0.19 |
| EPS (Diluted) | -$0.18 | -$0.15n/m | -$0.19 |
| Diluted Shares (Avg) | 72M | 51M0.0% | 51M |
Not reported in any period shown, so not listed: Income Tax.
SCAG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F |
|---|---|---|---|
| Total Assets | $26.5M+150.9% | $10.6M | N/A |
| Current Assets | $5.0M-41.4% | $8.6M | N/A |
| Cash & Equivalents | $91K-95.4% | $2.0M+1045.0% | $173K |
| Short-Term Investments | $0n/m | $0n/m | $0 |
| Inventory | $1.0M-39.2% | $1.7M | N/A |
| Accounts Receivable | $2.6M+28.7% | $2.0M | N/A |
| Long-Term Investments | $20.3Mn/m | $0n/m | $0 |
| Total Liabilities | $27.4M-25.0% | $36.6M | N/A |
| Current Liabilities | $25.4M+100.3% | $12.7M | N/A |
| Non-Current Liabilities | $2.0M+2227.4% | $87K | N/A |
| Total Equity | -$5.3Mn/m | -$26.0M | N/A |
| Retained Earnings | -$40.2Mn/m | -$27.3M | N/A |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
SCAG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F |
|---|---|---|---|
| Operating Cash Flow | -$5.9Mn/m | -$6.2Mn/m | -$4.9M |
| Depreciation & Amortization | $301K-44.5% | $542K+21.5% | $446K |
| Stock-Based Compensation | $1.8M | N/A | N/A |
| Capital Expenditures | $13K-73.7% | $51K-69.1% | $166K |
| Free Cash Flow | -$5.9Mn/m | -$6.3Mn/m | -$5.1M |
| Investing Cash Flow | -$20.7Mn/m | -$1.6Mn/m | -$166K |
| Financing Cash Flow | $24.7M+182.2% | $8.7M+41.4% | $6.2M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
SCAG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, Liabilities-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$5.3M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.20), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Scage Future SCAG | FY2025 | $11.1M | -$12.9M | N/A | $10.0M | 51/100 |
| Arts-Way Manufacturing Co Inc ARTW | FY2025 | $23.0M | $1.0M | 4.5% | $14.1M | 35/100 |
| Xos, Inc. XOS | FY2025 | $46.0M | -$25.3M | -55.0% | $38.7M | 55/100 |
| Hydrofarm Holdings Group, Inc. HYFM | FY2025 | $134.3M | -$289.8M | N/A | $3.4M | 15/100 |
| GreenPower Motor Company Inc. GP | FY2026 | $16.4M | -$5.5M | -33.4% | $2.3M | 36/100 |
| Gencor Industries, Inc. GENC | FY2025 | $115.4M | $15.7M | 13.6% | $250.6M | 69/100 |
Where Scage Future Ranks
Frequently Asked Questions
Scage Future (SCAG) reported $11.1M in total revenue for fiscal year 2025. This represents a 82.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Scage Future (SCAG) revenue grew by 82.0% year-over-year, from $6.1M to $11.1M in fiscal year 2025.
No, Scage Future (SCAG) reported a net loss of $12.9M in fiscal year 2025.
Scage Future (SCAG) had EBITDA of -$13.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
Scage Future (SCAG) had a gross margin of -6.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Scage Future (SCAG) recorded an outflow of $5.9M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Scage Future (SCAG) recorded an outflow of $5.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Scage Future (SCAG) had $26.5M in total assets as of fiscal year 2025, including both current and long-term assets.
Scage Future (SCAG) invested $13K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Scage Future (SCAG) invested $1.5M in research and development during fiscal year 2025.
Scage Future (SCAG) had a current ratio of 0.20 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Scage Future (SCAG) had a return on assets of -48.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Scage Future (SCAG) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $10.0M as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Scage Future (SCAG) trades at 0.9x sales, its market capitalization divided by $11.1M revenue, FY2025. The market capitalization is $10.0M as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2025, Scage Future (SCAG) held $20.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $5.9M over that year. Dividing the one by the other, the reported balance equals about 42 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Scage Future (SCAG) has negative shareholder equity of -$5.3M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Scage Future (SCAG) has an Altman Z-Score of -4.08, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Scage Future (SCAG) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Scage Future (SCAG) reported a net loss of $12.9M while operations used $5.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Scage Future (SCAG) reported an operating loss of $13.4M against $338K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
Scage Future (SCAG) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.